Xiao Zhong Gao

Description

The product is identified by the SPL code 34089-3. No additional relevant details are available regarding its chemical composition, structural formula, inactive ingredients, or other characteristics.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply one or two plasters to the affected area once daily. The plasters should be removed after 12 hours of application.

For children aged 2 to 12 years and adults with compromised health, the use of plasters should only occur under the guidance of a healthcare professional.

The product is contraindicated for use in children under 2 years of age; consultation with a doctor is advised in such cases.

Contraindications

The product is contraindicated in the following situations:

• Application on wounds, irritated, or damaged skin due to the potential for exacerbating the condition.

• Use if the product's appearance has changed, as this may indicate instability or contamination.

• Application for periods exceeding 12 hours, which may increase the risk of adverse effects.

• In individuals with known hypersensitivity to the product, to prevent allergic reactions.

• Use contrary to the provided directions, as this may lead to unintended consequences.

Additionally, while using this product, it is essential to avoid contact with the eyes or mucous membranes to prevent irritation. Bandaging should not be done tightly, and supervision is required when used by children. Caution is advised for individuals prone to allergic reactions.

Warnings and Precautions

For external use only. This product contains natural rubber latex, which may cause allergic reactions in sensitive individuals. Healthcare professionals should be aware of this allergy alert when recommending this product to patients.

General precautions must be observed to ensure safe use. Contact with the eyes or mucous membranes should be avoided to prevent irritation. Bandaging should not be applied tightly, as this may lead to complications. It is essential to supervise the use of this product by children to prevent accidental ingestion or misuse. Caution is advised for individuals with a history of allergic reactions.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be advised to discontinue use and consult a healthcare provider under the following circumstances: if the condition worsens; if symptoms persist for more than 7 days; if symptoms resolve and then recur within a few days; if excessive skin irritation develops; when using for arthritis-related pain; if pain persists for more than 10 days; if redness is observed; or in cases involving children under 12 years of age.

Side Effects

Patients using this product should be aware that it is for external use only. There is an allergy alert associated with this product, as it contains natural rubber latex, which may cause allergic reactions in some individuals.

Participants are advised to discontinue use and consult a doctor if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms resolve and then recur within a few days, excessive skin irritation develops, or if the product is being used for arthritis pain and the pain persists for more than 10 days. Additionally, patients should seek medical advice if redness is present or if the product is being used in children under 12 years of age.

Drug Interactions

Patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication if they are currently taking other medications. This precaution is essential to avoid potential drug interactions that may affect the efficacy or safety of the treatment.

There are no specific laboratory test interactions associated with this medication. However, it is always prudent for healthcare providers to consider the overall medication regimen of the patient when interpreting laboratory results.

Packaging & NDC

Below are the non-prescription pack sizes of Xiao Zhong Gao (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product; consultation with a healthcare professional is advised. For children aged 2 to 12 years and adults with compromised health, use is recommended only under the guidance of a physician.

For patients 12 years of age and older, the recommended application is one or two plasters to the affected area once daily, with removal after 12 hours. It is essential to supervise the use of this product in children and ensure it is kept out of their reach. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is necessary. Caution is advised when considering use in conditions affecting children under 12 years of age.

Geriatric Use

Elderly patients, defined as those aged 65 years and older, should be treated with caution when using this medication. For adults and children aged 12 years and older, the recommended application is one or two plasters to the affected area once daily, with removal after 12 hours.

In geriatric patients, particularly those with compromised health, it is advisable to use this medication only under the guidance of a healthcare provider. This recommendation is crucial to ensure safety and efficacy, as elderly patients may have different pharmacokinetic and pharmacodynamic responses compared to younger populations.

Healthcare providers should closely monitor elderly patients for any adverse effects and consider potential dose adjustments based on individual health status and response to treatment.

Pregnancy

Pregnant patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication. The potential risks and benefits should be carefully considered, as the effects of the medication on fetal outcomes are not fully established. It is essential for women of childbearing potential to seek guidance to ensure the safety of both the mother and the developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product in lactating mothers. Additionally, there are no statements available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Documentation of the incident, including the amount and timing of the overdose, is crucial for ongoing patient management and for informing any necessary follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to use the product on wounds, irritated, or damaged skin. Patients should be informed that the product should not be used if its appearance has changed and that it should not be applied for more than 12 hours.

Patients must be cautioned against using the product if they have a known hypersensitivity to it and should only use it as directed. They should be instructed to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, patients should be advised to seek medical advice if they experience excessive skin irritation, if they are using the product for arthritis pain, if pain persists for more than 10 days, or if redness is present.

For children under 12 years of age, healthcare providers should recommend consulting a doctor before use. Patients should be reminded to avoid contact with the eyes or mucous membranes while using the product and to refrain from tightly bandaging the area of application. Supervision is advised when the product is used by children, and patients should exercise caution if they are prone to allergic reactions.

Furthermore, patients should be encouraged to consult a doctor or pharmacist before using the product if they are pregnant or taking other medications.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored in a dry area at temperatures below 20ºC (68°F) to ensure optimal stability and efficacy. Proper storage conditions are essential for preserving the quality of the product.

Additional Clinical Information

The transdermal route of administration is indicated for patients aged 12 years and older, who should apply one or two plasters to the affected area once daily, removing them after 12 hours. For children aged 2 to 12 years and adults with compromised health, use should only occur under the guidance of a physician. The product is contraindicated for children under 2 years of age, and consultation with a doctor is advised in such cases.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Xiao Zhong Gao, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)